HKD 0.62
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 201.02 Million CNY | 246.86% |
2022 | 57.95 Million CNY | 291.27% |
2021 | 14.81 Million CNY | 35.63% |
2020 | 10.92 Million CNY | 162.27% |
2019 | 4.16 Million CNY | -74.96% |
2018 | 16.62 Million CNY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 180 Million CNY | 0.0% |
2023 Q4 | 201.02 Million CNY | 0.0% |
2023 FY | 201.02 Million CNY | 246.86% |
2023 Q2 | 137.92 Million CNY | 0.0% |
2022 FY | 57.95 Million CNY | 291.27% |
2022 Q4 | 65.06 Million CNY | 0.0% |
2022 Q2 | 41 Million CNY | 0.0% |
2021 Q2 | 19.08 Million CNY | 0.0% |
2021 FY | 14.81 Million CNY | 35.63% |
2021 Q4 | 18.11 Million CNY | 0.0% |
2020 Q2 | 1.75 Billion CNY | 0.0% |
2020 FY | 10.92 Million CNY | 162.27% |
2020 Q4 | 12.94 Million CNY | 0.0% |
2019 Q2 | - HKD | 0.0% |
2019 Q4 | 1.42 Billion CNY | 0.0% |
2019 FY | 4.16 Million CNY | -74.96% |
2018 FY | 16.62 Million CNY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 52.86 Million HKD | -280.237% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 96.611% |